Cargando…

Phase III trial of Covid-19 treatment paused for safety concerns

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644404/
http://dx.doi.org/10.1007/s40278-020-84759-3
_version_ 1783606448487399424
collection PubMed
description
format Online
Article
Text
id pubmed-7644404
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-76444042020-11-06 Phase III trial of Covid-19 treatment paused for safety concerns Reactions Weekly News Item Springer International Publishing 2020-10-24 2020 /pmc/articles/PMC7644404/ http://dx.doi.org/10.1007/s40278-020-84759-3 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
Phase III trial of Covid-19 treatment paused for safety concerns
title Phase III trial of Covid-19 treatment paused for safety concerns
title_full Phase III trial of Covid-19 treatment paused for safety concerns
title_fullStr Phase III trial of Covid-19 treatment paused for safety concerns
title_full_unstemmed Phase III trial of Covid-19 treatment paused for safety concerns
title_short Phase III trial of Covid-19 treatment paused for safety concerns
title_sort phase iii trial of covid-19 treatment paused for safety concerns
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644404/
http://dx.doi.org/10.1007/s40278-020-84759-3